Search
for
Sort by
Research 691–720 of 1000+
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- mTOR signaling in hair follicle and hair diseases: recent progress
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Phototherapy for alopecia areata
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Editorial: Targeted immunological therapies in dermatology
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Alopecia Areata: An Updated Review for 2023
- New and Emerging Therapies for Alopecia Areata
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.